Role of Epigenetic Modifications in Luminal Breast Cancer
Hany Abdel-Hafiz(University of Arizona), Kathryn B. Horwitz(University of Colorado Boulder)
Cited by 58
Related Papers
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
|Communications Biology|2020|170
The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers
|Cancer Research|2006|165
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
|Journal of Biological Chemistry|2002|146
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
|Science Advances|2019|126